The activist investor landed board seats on two critical strategic review groups, suggesting that a sale of two non-core business units could happen soon.
Starboard CEO Jeff Smith and two others are joining the board. The activist investor will also recommend two additional directors.
Other movers included Mannkind, Perrigo and Bristol-Myers Squibb.
Jim Cramer likes Harley and Enterprise Products Partners, but says stay away from Costamare and Achaogen.